(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity
The present invention provides (4-{4-[5-(Benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid which is useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
Novartis AG
A A A A A A A A C A A A A A C C C A A A A A A A A C A A C A A C A A C A C A A A A A C A A A C A A C
A61P A61P A61P A61K A61K A61P A61P A61P C07D A61P A61P A61K A61K A61P C07D C07D C07D A61P A61P A61P A61P A61K A61P A61P A61P C07D A61K A61P C07D A61P A61P C07D A61P A61P C07D A61K C07D A61P A61K A61K A61P A61P C07D A61K A61P A61K C07D A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Young-shin Wenming Michael H.
Kwak Liu Serrano-Wu